Back to overviewThe vital role of biomaterials in regenerative medicine
:brightness(undefined))
Biomaterials are reshaping regenerative medicine. At the intersection of biotechnology and patient care, these advanced materials are redefining how we restore and regenerate skin tissue. In today’s rapidly advancing medical landscape, patients not only seek results but expect safe, science-backed solutions that deliver predictable, measurable outcomes. Biomaterials now offer a more sophisticated, proven pathway to regeneration, meeting these elevated expectations with precision and confidence.
In its 20-year history, BTS has grown from 150 participants to over 1.000 professionals from more than 50 countries in recent editions. This impressive growth reflects the quality and influence of a congress characterised by its focus on innovation and scientific excellence. The continuous support from the industry enables the presence of a large and renowned panel of experts, guaranteeing a first-class scientific standard.
A clear commitment to scientific progress
This year’s edition of BTS marked a pivotal moment for the field: The convergence of biostimulation, regenerative science, and the evolving understanding of skin quality. Nordberg Medical took centre stage with four expert-led scientific sessions, each focused on deepening clinical understanding and offering practical insight into regenerative aesthetics.
At this year’s congress, Nordberg Medical presented a focused scientific programme highlighting key advances in regenerative aesthetics. Professor Dr. Martina Kerschner explored the biological foundations of skin quality and their clinical relevance. Dr. Pawel Kubik clarified the distinctions between biostimulation and regenerative approaches, a critical differentiation for treatment planning. Dr. Susanne Kristof demonstrated how regenerative injection techniques can deliver natural outcomes with procedural efficiency. The programme concluded with a panel featuring Dr. Chantal Sciuto, Dr. Kubik, and Dr. Kristof, who examined the clinical role of biocompatible biomaterials and their impact on setting new standards in aesthetic medicine.
Strategic partnerships. Clinical leadership.
At Nordberg Medical, we believe that advancing regenerative aesthetics requires more than innovation. It demands collaboration. Our presence at BTS 2025 reflects a long-term commitment to fostering partnerships with physicians who share our vision of aesthetic medicine: One that prioritises skin biology, long-term outcomes and patient safety.
As our presence grows across Europe, we continue to build a network of clinical leaders united by a shared mission to evolve the standards of care through regenerative science.
Biomaterials are reshaping regenerative medicine. At the intersection of biotechnology and patient care, these advanced materials are redefining how we restore and regenerate skin tissue. In today’s rapidly advancing medical landscape, patients not only seek results but expect safe, science-backed solutions that deliver predictable, measurable outcomes. Biomaterials now offer a more sophisticated, proven pathway to regeneration, meeting these elevated expectations with precision and confidence.
In its 20-year history, BTS has grown from 150 participants to over 1.000 professionals from more than 50 countries in recent editions. This impressive growth reflects the quality and influence of a congress characterised by its focus on innovation and scientific excellence. The continuous support from the industry enables the presence of a large and renowned panel of experts, guaranteeing a first-class scientific standard.
A clear commitment to scientific progress
This year’s edition of BTS marked a pivotal moment for the field: The convergence of biostimulation, regenerative science, and the evolving understanding of skin quality. Nordberg Medical took centre stage with four expert-led scientific sessions, each focused on deepening clinical understanding and offering practical insight into regenerative aesthetics.
At this year’s congress, Nordberg Medical presented a focused scientific programme highlighting key advances in regenerative aesthetics. Professor Dr. Martina Kerschner explored the biological foundations of skin quality and their clinical relevance. Dr. Pawel Kubik clarified the distinctions between biostimulation and regenerative approaches, a critical differentiation for treatment planning. Dr. Susanne Kristof demonstrated how regenerative injection techniques can deliver natural outcomes with procedural efficiency. The programme concluded with a panel featuring Dr. Chantal Sciuto, Dr. Kubik, and Dr. Kristof, who examined the clinical role of biocompatible biomaterials and their impact on setting new standards in aesthetic medicine.
:brightness(undefined))
Strategic partnerships. Clinical leadership.
At Nordberg Medical, we believe that advancing regenerative aesthetics requires more than innovation. It demands collaboration. Our presence at BTS 2025 reflects a long-term commitment to fostering partnerships with physicians who share our vision of aesthetic medicine: One that prioritises skin biology, long-term outcomes and patient safety.
As our presence grows across Europe, we continue to build a network of clinical leaders united by a shared mission to evolve the standards of care through regenerative science.
Read more related articles
:brightness(undefined))
